Home|Journals|Articles by Year|Audio Abstracts

Original Article

J Med Allied Sci. 2022; 12(2): 58-64

Association of novel obesity and lipid indices with chronic kidney disease risk in South Indians

Moonishaa Thiyagarajan Manjuladevi, Sivakumar Periyasamy, Abinaya Saraswathy.


Obesity has emerged as a risk factor for the Chronic kidney disease (CKD). Recent research propose novel obesity indices like Lipid accumulation product (LAP), Visceral adiposity index (VAI), Cardiometabolic index (CMI) to be associated with CKD risk. We aimed to evaluate the association between novel obesity indices and CKD risk indicators such as estimated glomerular filtration rate (eGFR), urine albumin excretion. Anthropometry measures, plasma lipids, eGFR estimation from serum creatinine and urine albumin creatinine ratio (urine ACR) were performed in 60 apparently healthy adults visiting the health checkup clinic. The subjects were divided based on Body mass index (BMI) as non-obese (n=22) and obese (n=38) groups. Their eGFR and urine ACR were compared using independent t-test or Mann-Whitney test. Spearman correlation test determined the association of obesity and lipid indices with eGFR, urine ACR. Anthropometric measures - BMI, WC (waist circumference), lipid indices - TC/HDLc, LDLc/HDLc ratios, and obesity indices - LAP, CMI were significantly higher in the obese group (p

Key words: Cardiometabolic index, Chronic kidney disease, Lipid accumulation product, Obesity, Visceral adiposity index

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.